BEAUFORT Trademark

Trademark Overview


On Friday, October 24, 2008, a trademark application was filed for BEAUFORT with the United States Patent and Trademark Office. The USPTO has given the BEAUFORT trademark a serial number of 77600189. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, March 7, 2019. This trademark is owned by Beaufort Advisors, LLC. The BEAUFORT trademark is filed in the Advertising, Business and Retail Services, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Regulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management

Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals

Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the...

Legal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and N...
beaufort

General Information


Serial Number77600189
Word MarkBEAUFORT
Filing DateFriday, October 24, 2008
Status800 - REGISTERED AND RENEWED
Status DateThursday, March 7, 2019
Registration Number3690806
Registration DateTuesday, September 29, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesRegulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management
Goods and ServicesConsulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals
Goods and ServicesContract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, devices and biologics
Goods and ServicesLegal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validation, namely, regulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvement, namely, providing independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Pseudo MarkBEAU FORT

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2009
Primary Code035
First Use Anywhere DateThursday, June 25, 2009
First Use In Commerce DateThursday, June 25, 2009

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2009
Primary Code040
First Use Anywhere DateThursday, June 25, 2009
First Use In Commerce DateThursday, June 25, 2009

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 28, 2008
Primary Code042
First Use Anywhere DateThursday, June 25, 2009
First Use In Commerce DateThursday, June 25, 2009

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 28, 2008
Primary Code045
First Use Anywhere DateThursday, June 25, 2009
First Use In Commerce DateThursday, June 25, 2009

Trademark Owner History


Party NameBEAUFORT, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNORFOLK, VA 23510

Party NameBeaufort Advisors, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNorfolk, VA 23510

Party NameBeaufort Advisors, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorfolk, VA 23510

Trademark Events


Event DateEvent Description
Thursday, March 7, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, March 7, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, March 7, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, March 7, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, February 3, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, September 29, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, June 20, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 20, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 25, 2015NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, September 25, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, September 24, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 14, 2015TEAS SECTION 8 RECEIVED
Wednesday, April 7, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 29, 2009REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, August 25, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 25, 2009ASSIGNED TO LIE
Thursday, August 20, 2009APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, August 20, 2009USE AMENDMENT ACCEPTED
Friday, August 7, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 6, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 6, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 4, 2009AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, August 4, 2009USE AMENDMENT FILED
Monday, August 3, 2009TEAS AMENDMENT OF USE RECEIVED
Wednesday, July 29, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 29, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 29, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 3, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 3, 2009NON-FINAL ACTION E-MAILED
Tuesday, February 3, 2009NON-FINAL ACTION WRITTEN
Tuesday, January 27, 2009ASSIGNED TO EXAMINER
Wednesday, October 29, 2008NOTICE OF PSEUDO MARK MAILED
Tuesday, October 28, 2008NEW APPLICATION ENTERED IN TRAM